The TGA has ignored the concerns of dermatologists and will allow over the counter sales of the topical retinoid adapalene from next year. In an interim decision announced on 10 June, the TGA’s Advisory Committee on Medicines Scheduling approved an application for adapalene to be down-scheduled to Schedule 3 ‘Pharmacist Only Medicine’. The decision means that ...
Topical retinoid to be sold OTC for acne
By Michael Woodhead
17 Jun 2020